Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Aeolus Pharmaceuticl
AOLSCurrent price
0.0001 USD
0 USD (0.00%)
Last closed
0.0001 USD
Company
www.aeoluspharma.com
ISIN
US00765G1094
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
PINK
Capitalization
167 294 USD
Yield for 12 month
0.00 %
1Y
3Y
5Y
10Y
15Y
AOLS
Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. The company develops a class of catalytic antioxidant compounds as medical countermeasures against nuclear, radiological, and chemical weapons, as well as for diseases and disorders of the respiratory system, central nervous system, and oncology. Its lead compound includes AEOL 10150 that has completed two Phase I clinical trials, which is developed against the pulmonary sub-syndrome of acute radiation syndrome; and for use as a medical countermeasure for exposure to chemical vesicants and nerve agents. The company is also developing AEOL 11114B, AEOL 11203, and AEOL 11207 for the treatment of Parkinson's disease, as well as AEOL 20415 for treating infectious diseases. Aeolus Pharmaceuticals, Inc. was founded in 1994 and is based in Mission Viejo, California. Address: 26361 Crown Valley Parkway, Mission Viejo, CA, United States, 92691
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1.25 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
+13 000 USD
Last Quarter
+129 000 USD
Current Year
–
Last Year
–
Current Quarter
-412 000 USD
Last Quarter
-465 000 USD
Key Figures AOLS
1 year
3 years
5 years
10 years
EBITDA
–
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-90.3 %
PEG Ratio
–
Return On Equity TTM
-186.43 %
Wall Street Target Price
1.25 USD
Revenue TTM
771 000 USD
Book Value
0.001 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-98 %
Dividend Yield
–
Gross Profit TTM
-805 000 USD
Earnings per share
–
Diluted Eps TTM
–
Most Recent Quarter
II 2017
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics AOLS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History AOLS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
16.07.2004
Dividend Date
–
Stock Valuation AOLS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.217
Price Sales TTM
0.217
Enterprise Value EBITDA
-0.0409
Price Book MRQ
0.8082
Financials AOLS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators AOLS
For 52 weeks
0.0001 USD
0.0001 USD
50 Day MA
0.0001 USD
Shares Short Prior Month
1 053
200 Day MA
0.0001 USD
Short Ratio
5.53
Shares Short
–
Short Percent
–
BeatStart